We all remember Representative Nancy Pelosi’s infamous statement that we have to pass the ObamaCare legislation so that we can find out what’s in it. That was in 2010 and Mrs. Pelosi was then speaker of the House of Representatives.
Well, Congress followed her advice and passed ObamaCare, formally known as the Patient Protection and Affordable Care Act. Three years later, in October of 2013, tens of millions of Americans began finding out what was really in the bill, as they began receiving health insurance cancellations and/or massive premium hikes. They also began to learn that under ObamaCare the IRS has been given new powers to go after them, their businesses, and their bank accounts. And that is only the beginning. As with all legislation, the devil is in the details, and lots of devils keep popping out of the constantly evolving details, as dozens of federal agencies continue churning out thousands of pages of regulations to implement the misbegotten, misnamed Affordable Care Act.
There are many important lessons from ObamaCare that we should apply to another huge project that could have a similarly devastating impact on our nation. In November 2009, President Obama announced his intention to have the United States participate in a so-called trade agreement known as the Trans-Pacific Partnership. I say so-called trade agreement because 80 percent of the proposed agreement deals with a great many issues besides trade.
The Trans-Pacific Partnership, or TPP, as it is called, is an all-out assault on our national sovereignty. It would unconstitutionally transfer legislative powers from the U.S. Congress, our state legislatures, and our city and county governments to multi-national corporations and unaccountable international bureaucrats at the World Trade Organization, or WTO. Incredibly, it also would transfer judicial powers from our federal and state courts — which are bad enough — to globalist TPP judges at regional tribunals and the WTO. It would also confer huge advantages on foreign businesses and large multinationals, while at the same time putting companies that operate here in America — especially small and medium-sized enterprises — at a competitive disadvantage. American businesses would remain shackled by the regulations of EPA, FDA, OSHA, etc. while their foreign competitors could operate here unimpeded by those same strictures.
Click here to read the entire article and view video.